Bangkok Lab And Cosmetic Balance Sheet Health
Financial Health criteria checks 5/6
Bangkok Lab And Cosmetic has a total shareholder equity of THB1.6B and total debt of THB280.2M, which brings its debt-to-equity ratio to 17.6%. Its total assets and total liabilities are THB2.2B and THB644.9M respectively. Bangkok Lab And Cosmetic's EBIT is THB200.2M making its interest coverage ratio 7.8. It has cash and short-term investments of THB975.5M.
Key information
17.6%
Debt to equity ratio
฿280.23m
Debt
Interest coverage ratio | 7.8x |
Cash | ฿975.49m |
Equity | ฿1.60b |
Total liabilities | ฿644.92m |
Total assets | ฿2.24b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BLC's short term assets (THB1.7B) exceed its short term liabilities (THB442.3M).
Long Term Liabilities: BLC's short term assets (THB1.7B) exceed its long term liabilities (THB202.7M).
Debt to Equity History and Analysis
Debt Level: BLC has more cash than its total debt.
Reducing Debt: Insufficient data to determine if BLC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: BLC's debt is well covered by operating cash flow (45%).
Interest Coverage: BLC's interest payments on its debt are well covered by EBIT (7.8x coverage).